Biblioteca Virtual em Saúde

Pesquisa | Influenza A (H1N1)

  • BIREME | OPAS | OMS logo
 
1.

Availability of a new candidate reassortant vaccine virus for pandemic (H1N1) 2009 virus vaccine development: NIBRG-121xp

Autor(es): World Health Organization - WHO
Fonte: s.l; World Health Organization; Aug. 6, 2009. 2 p.
Repositório Complementar ID: 264
Resumo: A new candidate reassortant vaccine virus (NIBRG-121xp) has been developed by extended egg passage of the reverse genetics technology derived reassortant NIBRG-121 originally developed from an A/California/7/2009(H1N1)v virus by the National Institute for Biological Standards and Control (NIBSC), Potters Bar, Hertfordshire, United Kingdom.